ARCHIVES

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

This article is from The Cancer Letter archive.

Vol. 39 No. 05 | February 1, 2013

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009

DRCCA Concept Approvals; RFP For Evolution Of Three Programs; RFA For Cancer Care Of Elderly, New Physician Investigator Awards

October 29, 1982

Separation Will Make Interaction Easier; AACR President Says

June 26, 1992

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007